S&P 500   3,378.77 (-0.05%)
DOW   27,926.33 (-0.18%)
QQQ   273.28 (+0.52%)
AAPL   457.67 (+1.25%)
MSFT   209.47 (+0.13%)
FB   260.76 (+0.33%)
GOOGL   1,522.53 (+1.01%)
AMZN   3,201.74 (+1.25%)
NVDA   463.06 (+1.19%)
CGC   17.50 (+1.45%)
TSLA   1,600.00 (+2.91%)
GE   6.71 (-0.15%)
MU   46.73 (-3.61%)
AMD   82.03 (-0.70%)
T   30.04 (-0.46%)
F   7.15 (+0.56%)
ACB   9.69 (-1.12%)
GILD   68.24 (-0.87%)
NFLX   477.14 (+0.35%)
DIS   131.99 (+0.15%)
BAC   26.55 (-0.67%)
BA   178.31 (+1.64%)
S&P 500   3,378.77 (-0.05%)
DOW   27,926.33 (-0.18%)
QQQ   273.28 (+0.52%)
AAPL   457.67 (+1.25%)
MSFT   209.47 (+0.13%)
FB   260.76 (+0.33%)
GOOGL   1,522.53 (+1.01%)
AMZN   3,201.74 (+1.25%)
NVDA   463.06 (+1.19%)
CGC   17.50 (+1.45%)
TSLA   1,600.00 (+2.91%)
GE   6.71 (-0.15%)
MU   46.73 (-3.61%)
AMD   82.03 (-0.70%)
T   30.04 (-0.46%)
F   7.15 (+0.56%)
ACB   9.69 (-1.12%)
GILD   68.24 (-0.87%)
NFLX   477.14 (+0.35%)
DIS   131.99 (+0.15%)
BAC   26.55 (-0.67%)
BA   178.31 (+1.64%)
S&P 500   3,378.77 (-0.05%)
DOW   27,926.33 (-0.18%)
QQQ   273.28 (+0.52%)
AAPL   457.67 (+1.25%)
MSFT   209.47 (+0.13%)
FB   260.76 (+0.33%)
GOOGL   1,522.53 (+1.01%)
AMZN   3,201.74 (+1.25%)
NVDA   463.06 (+1.19%)
CGC   17.50 (+1.45%)
TSLA   1,600.00 (+2.91%)
GE   6.71 (-0.15%)
MU   46.73 (-3.61%)
AMD   82.03 (-0.70%)
T   30.04 (-0.46%)
F   7.15 (+0.56%)
ACB   9.69 (-1.12%)
GILD   68.24 (-0.87%)
NFLX   477.14 (+0.35%)
DIS   131.99 (+0.15%)
BAC   26.55 (-0.67%)
BA   178.31 (+1.64%)
S&P 500   3,378.77 (-0.05%)
DOW   27,926.33 (-0.18%)
QQQ   273.28 (+0.52%)
AAPL   457.67 (+1.25%)
MSFT   209.47 (+0.13%)
FB   260.76 (+0.33%)
GOOGL   1,522.53 (+1.01%)
AMZN   3,201.74 (+1.25%)
NVDA   463.06 (+1.19%)
CGC   17.50 (+1.45%)
TSLA   1,600.00 (+2.91%)
GE   6.71 (-0.15%)
MU   46.73 (-3.61%)
AMD   82.03 (-0.70%)
T   30.04 (-0.46%)
F   7.15 (+0.56%)
ACB   9.69 (-1.12%)
GILD   68.24 (-0.87%)
NFLX   477.14 (+0.35%)
DIS   131.99 (+0.15%)
BAC   26.55 (-0.67%)
BA   178.31 (+1.64%)
Log in

NASDAQ:AXLAAxcella Health Stock Price, Forecast & News

$5.90
+0.01 (+0.17 %)
(As of 08/13/2020 10:19 AM ET)
Add
Compare
Today's Range
$5.84
Now: $5.90
$6.01
50-Day Range
$4.20
MA: $4.97
$5.83
52-Week Range
$2.25
Now: $5.90
$8.81
Volume763 shs
Average Volume194,436 shs
Market Capitalization$215.04 million
P/E RatioN/A
Dividend YieldN/A
Beta1.1
There is no company description available for Axcella Health Inc.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 4.5Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 4.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.22 out of 5 stars


Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:AXLA
CUSIPN/A
CIKN/A
Phone857-320-2200

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$2.55 per share

Profitability

Net Income$-59,040,000.00

Miscellaneous

EmployeesN/A
Market Cap$215.04 million
Next Earnings Date11/10/2020 (Estimated)
OptionableNot Optionable
$5.90
+0.01 (+0.17 %)
(As of 08/13/2020 10:19 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AXLA News and Ratings via Email

Sign-up to receive the latest news and ratings for AXLA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Axcella Health (NASDAQ:AXLA) Frequently Asked Questions

How has Axcella Health's stock price been impacted by Coronavirus (COVID-19)?

Axcella Health's stock was trading at $3.32 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, AXLA shares have increased by 77.7% and is now trading at $5.90.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Axcella Health?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Axcella Health in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Axcella Health
.

When is Axcella Health's next earnings date?

Axcella Health is scheduled to release its next quarterly earnings announcement on Tuesday, November 10th 2020.
View our earnings forecast for Axcella Health
.

How were Axcella Health's earnings last quarter?

Axcella Health Inc (NASDAQ:AXLA) announced its earnings results on Wednesday, August, 5th. The company reported ($0.48) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.56) by $0.08.
View Axcella Health's earnings history
.

What price target have analysts set for AXLA?

5 equities research analysts have issued 12 month price targets for Axcella Health's shares. Their forecasts range from $9.00 to $28.00. On average, they anticipate Axcella Health's stock price to reach $17.60 in the next year. This suggests a possible upside of 198.3% from the stock's current price.
View analysts' price targets for Axcella Health
.

Has Axcella Health been receiving favorable news coverage?

Media stories about AXLA stock have trended extremely negative on Thursday, according to InfoTrie Sentiment Analysis. The research group rates the sentiment of media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Axcella Health earned a news sentiment score of -4.1 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the next several days.
View the latest news about Axcella Health
.

Are investors shorting Axcella Health?

Axcella Health saw a increase in short interest in June. As of June 15th, there was short interest totaling 66,000 shares, an increase of 23.8% from the May 31st total of 53,300 shares. Based on an average daily volume of 267,800 shares, the short-interest ratio is presently 0.2 days. Currently, 0.4% of the shares of the stock are short sold.
View Axcella Health's Short Interest
.

Who are some of Axcella Health's key competitors?

What other stocks do shareholders of Axcella Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Axcella Health investors own include NVIDIA (NVDA), Sorrento Therapeutics (SRNE), Livongo Health (LVGO), Myovant Sciences (MYOV), Occidental Petroleum (OXY), Coty (COTY), Energy Transfer LP Unit (ET), Main Street Capital (MAIN), VBI Vaccines (VBIV) and Viking Therapeutics (VKTX).

When did Axcella Health IPO?

(AXLA) raised $76 million in an initial public offering on Thursday, May 9th 2019. The company issued 3,600,000 shares at $20.00-$22.00 per share. Goldman Sachs, J.P. Morgan and SVB Leerink acted as the underwriters for the IPO.

What is Axcella Health's stock symbol?

Axcella Health trades on the NASDAQ under the ticker symbol "AXLA."

Who are Axcella Health's major shareholders?

Axcella Health's stock is owned by many different retail and institutional investors. Top institutional shareholders include Monashee Investment Management LLC (0.62%), EAM Investors LLC (0.25%), Bank of New York Mellon Corp (0.10%), Goldman Sachs Group Inc. (0.07%), Virtu Financial LLC (0.06%) and State of Wisconsin Investment Board (0.03%). Company insiders that own Axcella Health stock include Catherine A Sohn, D Clay Bretches, David R Epstein, Laurent Chardonnet and Ventures Fund Iv LP Flagship.
View institutional ownership trends for Axcella Health
.

Which major investors are buying Axcella Health stock?

AXLA stock was purchased by a variety of institutional investors in the last quarter, including Monashee Investment Management LLC, EAM Investors LLC, Goldman Sachs Group Inc., Virtu Financial LLC, State of Wisconsin Investment Board, Bank of New York Mellon Corp, and Leap Investments LP. Company insiders that have bought Axcella Health stock in the last two years include Catherine A Sohn, D Clay Bretches, David R Epstein, Laurent Chardonnet, and Ventures Fund Iv LP Flagship.
View insider buying and selling activity for Axcella Health
.

How do I buy shares of Axcella Health?

Shares of AXLA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Axcella Health's stock price today?

One share of AXLA stock can currently be purchased for approximately $5.90.

How big of a company is Axcella Health?

Axcella Health has a market capitalization of $215.04 million. The company earns $-59,040,000.00 in net income (profit) each year or ($3.55) on an earnings per share basis.

What is Axcella Health's official website?

The official website for Axcella Health is www.axcellahealth.com.

How can I contact Axcella Health?

Axcella Health's mailing address is 840 MEMORIAL DRIVE, CAMBRIDGE MA, 02139. The company can be reached via phone at 857-320-2200.

This page was last updated on 8/13/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.